Alphyn Biologics

About:

Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases.

Website: https://alphynbiologics.com

Top Investors: Angel Physicians Fund, Queen City Angels, Serial Stage Venture Partners

Description:

Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.

Total Funding Amount:

$11.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cincinnati, Ohio, United States

Founded Date:

2019-01-01

Founders:

Neal Koller

Number of Employees:

1-10

Last Funding Date:

2024-04-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai